Price T Rowe Associates Inc Pacira Bio Sciences, Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 41,306 shares of PCRX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,306

Previous 50,715 18.55%

Holding current value

$1.04 Million

Previous $764,000 1.96%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$15.3 - $20.33 $143,957 - $191,284	-9,409 Reduced 18.55%	41,306 $779,000
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $2.32 Million - $5.65 Million	-198,429 Reduced 79.64%	50,715 $764,000
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $2.11 Million - $2.61 Million	-82,876 Reduced 24.96%	249,144 $7.13 Million
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $1.99 Million - $2.55 Million	-71,733 Reduced 17.77%	332,020 $9.7 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $137,811 - $179,647	-5,236 Reduced 1.28%	403,753 $13.6 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $44,393 - $58,010	1,447 Added 0.36%	408,989 $12.5 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $45,366 - $59,660	1,256 Added 0.31%	407,542 $16.3 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $76,886 - $93,874	2,164 Added 0.54%	406,286 $16.6 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $421,923 - $634,707	11,048 Added 2.81%	404,122 $15.6 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $224,636 - $258,173	4,384 Added 1.13%	393,074 $20.9 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $562,528 - $891,917	10,925 Added 2.89%	388,690 $22.7 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $138,309 - $176,232	2,304 Added 0.61%	377,765 $28.8 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $185,787 - $240,939	3,873 Added 1.04%	375,461 $22.6 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $112,776 - $126,523	-2,064 Reduced 0.55%	371,588 $20.8 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $573,395 - $678,133	9,689 Added 2.66%	373,652 $22.7 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $315,885 - $419,795	-5,326 Reduced 1.44%	363,963 $25.5 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $18.6 Million - $24.5 Million	369,289 New	369,289 $22.1 Million

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.8M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.15B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Pacira Bio Sciences, Inc. Transaction History